Short description
Neuron23 is a developer of drugs intended to treat Parkinson's disease and Alzheimer's disease.
Description
Neuron23 is a developer of drugs intended to treat Parkinson's disease and Alzheimer's disease.
The company was founded in 2018 and is based in San Francisco, California, United States.
Last funding
Noaccessforu
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
San Francisco, California, United States, North America
Founded on
January 1, 2018
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$56378 - 90123
Sign in for full access
Investors
No Way, Noaccessforu, Absolutely Noaccess, Absolutely Noaccess, Uh Ohhhh, Nopepepe, No Way, Blurry Noaccess, Noway Youcantaccess, Absolutely Noaccess
Sign in for full access
Founders
Adam Knight